<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00937742</url>
  </required_header>
  <id_info>
    <org_study_id>PKE TOMATO</org_study_id>
    <nct_id>NCT00937742</nct_id>
  </id_info>
  <brief_title>The Effect of Processed Tomato Products on CVD Risks</brief_title>
  <acronym>TOMATO</acronym>
  <official_title>The Effect of Processed Tomatoes on Endothelium- and Platelet- Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tomato Products Wellness Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Penn State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary working hypothesis is that consuming processed tomatoes frequently/daily will
      favorably improve endothelium and platelet function disease-risk biomarker profiles in adult
      men and women compared to consuming no or relatively low amounts of processed tomatoes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet and monocyte function/activity</measure>
    <time_frame>Baseline and end of intervention phase (week 6)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Vascular function</measure>
    <time_frame>Baseline and end of intervention phase (week 6)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lipids</measure>
    <time_frame>Baseline and end of intervention phase (week 6)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin/Glucose</measure>
    <time_frame>Baseline and end of intervention phase (week 6)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Markers</measure>
    <time_frame>Baseline and end of intervention phase (week 6)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Non-tomato products</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-tomato products (i.e. teriyaki marinade, sprite, applesauce) to be consumed daily in replace of tomato products</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tomato products</intervention_name>
    <description>Specified amounts of tomato products (i.e. tomato juice, ketchup, salsa, tomato soup, spaghetti sauce) to be consumed daily during a 6 week intervention phase.</description>
    <arm_group_label>Non-tomato products</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        men and women (&gt;21 &lt;70 years) nonsmokers, with a body mass index (BMI) ranging of 25 to 35
        kg/m2, BP &lt; or = 140/90 mmHg

        Exclusion Criteria:

          1. Total cholesterol (TC) is greater than 300 mg/dL;

          2. Fasting triglyceride is greater than 300 mg/dL;

          3. LDL cholesterol (LDL-C) is greater than 180 mg/dL;

          4. Female subjects who are pregnant or lactating;

          5. Subjects who are actively losing weight or trying to lose weight;

          6. Subjects with known allergy or intolerance to tomato products;

          7. taking any medications that would interfere with outcomes of the study, ie. lipid
             lowering medications, anti-inflammatory drugs, dietary supplements, such as fish oil
             or evening primrose;

          8. subjects' with documented atherosclerotic disease, inflammatory disease, diabetes
             mellitus, uncontrolled hypertension (&gt;=140/90 mm Hg - ok if controlled below this
             limit with medication), or other systemic diseases;

          9. subjects with low hematological counts as determined by &gt;or &lt;15% the upper or lower
             cut-off values of normal established for the lab;

         10. Smokers. -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Penny M Kris-Etherton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn State University</name>
      <address>
        <city>University Park</city>
        <state>Pennsylvania</state>
        <zip>16802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2009</study_first_submitted>
  <study_first_submitted_qc>July 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2009</study_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Penn State University</investigator_affiliation>
    <investigator_full_name>Penny Kris-Etherton</investigator_full_name>
    <investigator_title>Distinguished Professor of Nutrition</investigator_title>
  </responsible_party>
  <keyword>cardiovascular disease</keyword>
  <keyword>Lycopene</keyword>
  <keyword>Tomato</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

